# TC BioPharm (Holdings) plc (TCBP)

Source: https://www.quantisnow.com/company/TCBP
Generated: 2026-11-11T17:42:46.641Z

- Ticker: TCBP
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Biological Products (No Diagnostic Substances)
- IPO year: 2022
- Website: https://www.tcbiopharm.com

## About

TC Biopharm (Holdings) Plc, a clinical-stage biopharmaceutical company, focuses on developing immunotherapy products based on its allogeneic gamma delta T cell platform. Its product pipeline includes OmnImmune, an unmodified cell therapy used in the treatment of acute myeloid leukemia; and ImmuniStim, an unmodified cell therapy to treat COVID-19. The company was founded in 2013 and is headquartered in Motherwell, the United Kingdom.

## Latest TCBP news and filings

- 2025-06-11 12:30 UTC [TC BioPharm Announces Complete Response in Minimal Residual Disease (MRD) Patient](https://www.quantisnow.com/insight/tc-biopharm-announces-complete-response-in-minimal-residual-disease-mrd-6081595)
- 2025-03-21 15:22 UTC [SEC Form 6-K] [SEC Form 6-K filed by TC BioPharm (Holdings) plc](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-tc-biopharm-holdings-plc-5955608)
- 2025-03-21 14:45 UTC [TCBP Announces Transition from Nasdaq to OTC Markets](https://www.quantisnow.com/insight/tcbp-announces-transition-from-nasdaq-to-otc-markets-5955580)
- 2025-03-18 12:03 UTC [TCBP Announces Outsourcing Initiatives, Reducing Burn Rate and Overhead](https://www.quantisnow.com/insight/tcbp-announces-outsourcing-initiatives-reducing-burn-rate-and-overhead-5948743)
- 2025-03-05 13:30 UTC [TCBP Announces Non-Binding Letter of Intent to Acquire Commercial Stage Ophthalmic Pharmaceutical Company](https://www.quantisnow.com/insight/tcbp-announces-non-binding-letter-of-intent-to-acquire-commercial-stage-5927198)
- 2025-02-20 13:00 UTC [TCBP CEO Bryan Kobel to Participate on Cancer Progress Panel at 18th Annual European Life Sciences CEO Forum](https://www.quantisnow.com/insight/tcbp-ceo-bryan-kobel-to-participate-on-cancer-progress-panel-5899211)
- 2025-02-13 13:30 UTC [TCBP Announces Successful Completion of Cohort A in the ACHIEVE Clinical Trial](https://www.quantisnow.com/insight/tcbp-announces-successful-completion-of-cohort-a-in-the-achieve-5886454)
- 2025-02-10 21:05 UTC [SEC Form 6-K] [SEC Form 6-K filed by TC BioPharm (Holdings) plc](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-tc-biopharm-holdings-plc-5879698)
- 2025-02-10 15:00 UTC [TCBP Announces Successful Completion of Initial Cohort B Patient Dosing in the ACHIEVE Clinical Trial](https://www.quantisnow.com/insight/tcbp-announces-successful-completion-of-initial-cohort-b-patient-dosing-5879147)
- 2025-02-05 17:00 UTC [TCBP to Implement ADS Ratio Change](https://www.quantisnow.com/insight/tcbp-to-implement-ads-ratio-change-5872267)
- 2025-01-15 13:30 UTC [TCBP Announces H5N1 Proof of Concept Studies Intention](https://www.quantisnow.com/insight/tcbp-announces-h5n1-proof-of-concept-studies-intention-5846549)
- 2025-01-13 13:45 UTC [Conference Announcement] [TCBP to Present at Sequire Investor Summit 2025](https://www.quantisnow.com/insight/tcbp-to-present-at-sequire-investor-summit-2025-5843530)
- 2025-01-08 21:16 UTC [SEC Form 6-K] [SEC Form 6-K filed by TC BioPharm (Holdings) plc](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-tc-biopharm-holdings-plc-5839732)
- 2025-01-08 21:15 UTC [SEC Form 6-K] [SEC Form 6-K filed by TC BioPharm (Holdings) plc](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-tc-biopharm-holdings-plc-5839712)
- 2024-12-30 15:30 UTC [Dividends] [/C O R R E C T I O N -- TC BioPharm/](https://www.quantisnow.com/insight/c-o-r-r-e-c-t-i-o-n-5836424)
- 2025-01-06 18:30 UTC [TCBP Trading Continues Unabated on Nasdaq Stock Exchange](https://www.quantisnow.com/insight/tcbp-trading-continues-unabated-on-nasdaq-stock-exchange-5834365)
- 2024-12-31 19:10 UTC [SEC Form 6-K] [SEC Form 6-K filed by TC BioPharm (Holdings) plc](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-tc-biopharm-holdings-plc-5827702)
- 2024-12-31 15:15 UTC [TCBP Provides Update on Acquisition Strategy and Current Targets](https://www.quantisnow.com/insight/tcbp-provides-update-on-acquisition-strategy-and-current-targets-5827597)
- 2024-12-30 19:15 UTC [SEC Form 6-K] [SEC Form 6-K filed by TC BioPharm (Holdings) plc](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-tc-biopharm-holdings-plc-5826753)
- 2024-12-30 15:30 UTC [Dividends] [TCBP Issues 25% Stock Dividend](https://www.quantisnow.com/insight/tcbp-issues-25-stock-dividend-5826652)
- 2024-12-20 13:30 UTC [TCBP Advances ACHIEVE Phase 2b Clinical Trial with Final Dosing of 3 Patients](https://www.quantisnow.com/insight/tcbp-advances-achieve-phase-2b-clinical-trial-with-final-dosing-5821541)
- 2024-12-18 13:30 UTC [Dividends] [TCBP Announces General Meeting of Shareholders to Approve One-Time Shareholder Dividend](https://www.quantisnow.com/insight/tcbp-announces-general-meeting-of-shareholders-to-approve-one-time-shareholder-5818202)
- 2024-12-17 13:30 UTC [SEC Form 6-K] [SEC Form 6-K filed by TC BioPharm (Holdings) plc](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-tc-biopharm-holdings-plc-5816175)
- 2024-12-16 22:30 UTC [SEC Form 424B5] [SEC Form 424B5 filed by TC BioPharm (Holdings) plc](https://www.quantisnow.com/insight/sec-form-424b5-filed-by-tc-biopharm-holdings-plc-5815471)
- 2024-12-16 21:05 UTC [SEC Form 6-K] [SEC Form 6-K filed by TC BioPharm (Holdings) plc](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-tc-biopharm-holdings-plc-5814772)
- 2024-12-12 05:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by TC BioPharm (Holdings) plc](https://www.quantisnow.com/insight/sec-form-effect-filed-by-tc-biopharm-holdings-plc-5810217)
- 2024-12-11 12:00 UTC [TCBP Partners with CareDx to Support ACHIEVE Clinical Trial Using AlloCell for Pharmacokinetic Monitoring of Allogeneic Cell Therapy](https://www.quantisnow.com/insight/tcbp-partners-with-caredx-to-support-achieve-clinical-trial-using-5808472)
- 2024-12-04 13:30 UTC [TCBP Provides Quarterly Update on the ACHIEVE (UK) Clinical Trial](https://www.quantisnow.com/insight/tcbp-provides-quarterly-update-on-the-achieve-uk-clinical-trial-5799608)
- 2024-11-27 21:05 UTC [SEC Form F-3 filed by TC BioPharm (Holdings) plc](https://www.quantisnow.com/insight/sec-form-f-3-filed-by-tc-biopharm-holdings-plc-5793450)
- 2024-11-25 21:05 UTC [SEC Form 6-K] [SEC Form 6-K filed by TC BioPharm (Holdings) plc](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-tc-biopharm-holdings-plc-5790166)
- 2024-11-14 21:41 UTC [SEC Schedule 13G] [Amendment: SEC Form SC 13G/A filed by TC BioPharm (Holdings) plc](https://www.quantisnow.com/insight/amendment-sec-form-sc-13ga-filed-by-tc-biopharm-holdings-5776641)
- 2024-11-12 14:30 UTC [TCBP Awarded Non-Dilutive Funding, ScaleReady's G-Rex® Grant](https://www.quantisnow.com/insight/tcbp-awarded-non-dilutive-funding-scalereadys-g-rex-grant-5765522)
- 2024-10-30 12:30 UTC [TCBP Provides Shareholder Update and Highlights Recent Milestone Achievements](https://www.quantisnow.com/insight/tcbp-provides-shareholder-update-and-highlights-recent-milestone-achievements-5743104)
- 2024-10-25 13:45 UTC [TCBP Responds to False Social Media Claim](https://www.quantisnow.com/insight/tcbp-responds-to-false-social-media-claim-5738277)
- 2024-10-22 12:30 UTC [TCBP Enters Research Planning Collaboration with Dr. Carlos Maluquer de Motes for Mpox Therapeutic](https://www.quantisnow.com/insight/tcbp-enters-research-planning-collaboration-with-dr-carlos-maluquer-de-5732814)
- 2024-10-11 20:05 UTC [SEC Form 6-K] [SEC Form 6-K filed by TC BioPharm (Holdings) plc](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-tc-biopharm-holdings-plc-5723415)
- 2024-10-03 12:30 UTC [TCBP Announces Artificial Intelligence Initiative with Partner Carnegie Mellon University for Donor Screening](https://www.quantisnow.com/insight/tcbp-announces-artificial-intelligence-initiative-with-partner-carnegie-mellon-university-5714449)
- 2024-09-25 12:30 UTC [TCBP Announces Site Opening of Guys and St. Thomas Hospital](https://www.quantisnow.com/insight/tcbp-announces-site-opening-of-guys-and-st-thomas-hospital-5704268)
- 2024-09-24 12:45 UTC [Conference Announcement] [TCBP to Present at the 2024 ThinkEquity Conference in NYC](https://www.quantisnow.com/insight/tcbp-to-present-at-the-2024-thinkequity-conference-in-nyc-5703051)
- 2024-09-12 12:30 UTC [TCBP Announces First Patient Completed the Full Fose Regimen in ACHIEVE Clinical Trial](https://www.quantisnow.com/insight/tcbp-announces-first-patient-completed-the-full-fose-regimen-in-5691510)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/TCBP
- Earnings history: https://www.quantisnow.com/earnings/TCBP
- Dividend history: https://www.quantisnow.com/dividends/TCBP
- Insider transactions: https://www.quantisnow.com/insiders/TCBP
- Options chain: https://www.quantisnow.com/options/TCBP
- SEC 8-K filings only: https://www.quantisnow.com/company/TCBP/8-k
- RSS and alerts for TCBP: https://www.quantisnow.com/docs/rss-feeds.md